Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …

The treatment of chronic kidney disease (CKD) and of end-stage renal disease (ESRD)
imposes substantial societal costs. Expenditure is highest for renal replacement therapy …

Large cohort studies suggest that high convective volumes associated with online
hemodiafiltration may reduce the risk of mortality/morbidity compared to optimal high-flux …

Rationale & Objective Clinical practice guidelines discourage the use of central venous
catheters (CVCs) for vascular access in dialysis. However, some patients have inadequate …

Although mortality risk scores for chronic hemodialysis (HD) patients should have an
important role in clinical decision-making, those currently available have limited …

The vascular access is the lifeline for the hemodialysis patient. In the United States, the
Fistula First Breakthrough Initiative (FFBI) has been influential in improving use of …

A brief comprehensive overview is provided of the elements constituting the burden of
kidney disease [chronic kidney disease (CKD) and acute kidney injury]. This publication can …

Increased life expectancy, attributed to improved access to healthcare and drug
development, has led to an increase in multimorbidity, a key contributor to polypharmacy …

Results During a mean duration of 1.8±1.3 years (maximum of 5 years), the Korean PD
group had a higher mortality rate than the Korean HD group (hazard ratio [HR], 1.20 [95 …

Background Although dialysis prolongs life for patients with end-stage kidney disease, 20%
of deaths in this population are preceded by dialysis therapy withdrawal. Recently, there has …